Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Building Partnerships to Advance Research


StrokeNet is a new way of operating and conducting collaborative clinical National Institutes of Health (NIH) trials nationwide. University Hospitals is the Regional Coordinating Center for the major regional healthcare institutions that conduct NIH stroke and neurology research. Being selected as the Regional Coordinating Center is unique because all institutions and the corresponding satellite hospitals will operate and conduct clinical research trials under one financial budget and contract and utilize one central Institutional Review Board (IRB). In addition, this will allow us to maximize efficiencies in the development, promotion, and conduct of multisite exploratory phase I, II, and confirmatory phase III clinical trials in stroke prevention, treatment, and recovery funded by NIH.

Cleveland Alzheimer’s Disease Research Center (CADRC)

The CADRC is a collaborative project between University Hospitals, Case Western Reserve University, Cleveland Clinic, The MetroHealth System and the Louis Stokes Cleveland VA Medical Center. The Center is a National Institute of Aging Center that aims to increase the speed of research on aging-related brain disorders.

Alzheimer’s Clinical Trials Consortium (ACTC)

The ACTC provides optimal infrastructure utilizing centralized resources and shared expertise to accelerate the development of effective interventions for Alzheimer’s disease and related disorders. We are one of the 35 member sites of the ACTC with expertise in Alzheimer’s disease and related disorders clinical trials. Rajeet Shrestha, MD, is the Principal Investigator and serves on the ACTC Steering Committee. Participating Sites are active in one or more ACTC projects.

Global Alzheimer’s Platform Foundation (GAP)

GAP is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those living with Alzheimer’s by reducing the time and cost of Alzheimer’s disease (AD) clinical trials. The GAP-Net is a network of over 90 clinical trial sites across North America, including the Brain Health and Memory Centers at University Hospitals, who benefit from sharing knowledge and experience in order to effectively and efficiently work toward research progress in neurodegenerative conditions.